¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå ¼ºÀå°ú µ¿Çâ:
Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼¿¡ µû¸£¸é, ¼¼°è ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö 7.2%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â±îÁö 88¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾Ï, ¸¸¼º ½ÉÀåÁúȯ, ½Å°æÁúȯ, Á¤Çü¿Ü°ú Áúȯ µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀåÀÇ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ¾ÏÇùȸ¿¡ µû¸£¸é, 2019³â 1¿ù ħ½À¼º ¾Ï º´·ÂÀÌ ÀÖ´Â ¹Ì±¹ÀÎÀº 1,690¸¸ ¸í ÀÌ»óÀÌ »ýÁ¸ÇØ ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
ÀÌ·¯ÇÑ Àå¾Ö°¡ ¹ß»ýÇϱ⠽¬¿î ³ëÀÎ Àα¸ÀÇ Áõ°¡µµ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå °³Ã´À» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¿äÀÎÀÔ´Ï´Ù. ¹Ì±¹ Àα¸Á¶»ç±¹¿¡ µû¸£¸é, 2020³â ¹Ì±¹ ³» 65¼¼ ÀÌ»ó ¼ºÀÎ Àα¸´Â 5,400¸¸ ¸í ÀÌ»óÀ̾ú½À´Ï´Ù. ¼ºÇü ¹× Àç°Ç ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö´Â °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. °¡Ã³ºÐ ¼ÒµæÀÇ Áõ°¡¿Í ½ÅÈï±¹ÀÇ ÀÇ·á °ü±¤ ºÎ¹®ÀÇ È£È²µµ ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
COVID-19ÀÇ ´ëÀ¯ÇàÀ¸·Î ÀÎÇØ Àüü ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀåÀÇ ¸ÅÃâÀÌ Å©°Ô °¨¼ÒÇßÀ¸¸ç, COVID-19 °¨¿° ȯÀÚ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ¼±ÅÃÀû ¼ö¼úÀÌ ¿¬±âµÇ¸é¼ ¼ö¼ú °Ç¼ö°¡ °¨¼ÒÇÏ¿© ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÇÏÁö¸¸, ¸·´ëÇÑ ¼ö¼ú Àûü, ¿Ü°ú ÀÇ»ç¿Í ÀÇ·á ½Ã¼³ÀÇ ³ôÀº ¼öÀͰú ¼ö¿ä¿Í °ø±ÞÀÇ °ÝÂ÷¸¦ ÇØ¼ÒÇϱâ À§ÇÑ ³ë·ÂÀÇ Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº Å©°Ô ȸº¹µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼°è°¡ ¸¶Ä§³» ÆÒµ¥¹ÍÀ» ±Øº¹Çϰí ȸº¹ÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ½ÃÀåÀº À¯¸®ÇÑ ±âȸ¸¦ º¸À̰í ÀÖ½À´Ï´Ù.
ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Áý°Ô ºÐ¾ß´Â »ç¿ë ºóµµ Áõ°¡·Î ÀÎÇØ 2024³â 21.0%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Áý°Ô´Â ¼ö¼ú Áß Á¶Á÷À» Àâ°í, °íÁ¤Çϰí, Á¶ÀÛÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, Á¤È®¼º°ú Á¦¾î·ÂÀ» Á¦°øÇÕ´Ï´Ù.
- ÆÄÁö±â ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 9.4%ÀÇ CAGR·Î °¡Àå Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÆÄÁö±â´Â ¼¶¼¼ÇÑ ¼ö¼ú Áß Á¶Á÷À» Àâ°í, Á¶ÀÛÇϰí, Á¦°ÅÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, Á¤¹Ðµµ¿Í Á¦¾î·ÂÀ» Çâ»ó½Ãŵ´Ï´Ù.
- Á¤Çü¿Ü°ú ºÎ¹®Àº ±Ù°ñ°Ý°è(MSK) ÁúȯÀÇ ³ôÀº ¹ßº´·ü°ú ÃÖ¼Òħ½À¼ö¼úÀÇ ½ÃÀå °³Ã´ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î 2024³â 20.9%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ½Å°æ¿Ü°ú ºÎ¹®Àº ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÇÚµåÇïµå ¼ö¼ú ±â±â ½ÃÀå¿¡¼ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- º´¿ø ºÎ¹®Àº 2024³â 69.4%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- Ŭ¸®´Ð°ú ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿¡¼´Â ¹Ì¿ë¼ºÇü¼ö¼úÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó ±Þ°ÝÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
- ºÏ¹Ì ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀåÀº 2024³â ¼¼°è ¸ÅÃâ Á¡À¯À²ÀÇ 40.6%¸¦ Â÷ÁöÇϸç Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇß½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óºÎ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå ºÐ¼® Åø
- ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : Á¦Ç°º° º¯µ¿ ºÐ¼®
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : Á¦Ç°º° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®(2018-2030³â)
- °âÀÚ
- ¸®Æ®·¢ÅÍ
- È®Àå±â
- ±×·¡½ºÆÛ
- ¸Þ½º
- ij´¼¶ó
- ÇǺκÐÀý
- Åõ°üħ
- ±âŸ
Á¦5Àå ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : ¿ëµµº° º¯µ¿ ºÐ¼®
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : ¿ëµµº° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®(2018-2030³â)
- Á¤Çü¿Ü°ú
- ½ÉÀ庴ÇÐ
- ¾È°ú
- â»ó°ü¸®
- û°¢ÇÐ
- ÈäºÎ¿Ü°ú
- ºñ´¢±â°ú¡¤ºÎÀΰú ¿Ü°ú
- ¼ºÇü¿Ü°ú
- ½Å°æ¿Ü°ú
Á¦6Àå ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° º¯µ¿ ºÐ¼®
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®(2018-2030³â)
- º´¿ø
- Ŭ¸®´Ð
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- ±âŸ
Á¦7Àå ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ª ´ë½Ãº¸µå
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : Áö¿ªº° º¯µ¿ ºÐ¼®
- ÇÚµåÇïµå ¼ö¼ú±â±¸ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®(2018-2030³â)
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®(2018-2030³â)
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï ±¸µµ
- ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
- ÁÖ¿ä ±â¾÷ °³¿ä
- Zimmer Biomet
- B. Braun Melsungen AG
- Integra LifeSciences Corporation
- . Medtronic, plc.
- Smith &Nephew
- Zimmer Biomet Holdings
- Johnson & Johnson Services, Inc.
- Becton, Dickinson and Company
- CooperSurgical, Inc.
- Thompson Surgical Instruments Inc.
- Aspen Surgical
ksm 25.02.04
Hand-held Surgical Instruments Market Growth & Trends:
The global hand-held surgical instruments market size is expected to reach USD 8.8 billion by 2030, registering a CAGR of 7.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases, such as; cancer, chronic heart, neurological, orthopedic disorders is the leading factor driving the demand for hand-held surgical instruments market. According to the American Cancer Society, more than 16.9 million Americans with a history of invasive cancer were alive in January 2019.
The increasing geriatric population that is more susceptible to developing these disorders is another factor that is expected to propel market growth over the forecast period. According to the U.S. Census Bureau, there were more than 54 million adults aged 65 and older that lived in the U.S. in 2020. Increasing preference for plastic & reconstructive surgeries is another major factor driving the market growth. Increasing disposable income and the booming medical tourism sector in developing countries is also expected to boost the growth of the hand-held surgical instruments market.
The COVID-19 pandemic led to a significant downfall in overall sales of the hand-held surgical instruments market. Increasing focus on COVID-19-infected patients and postponement of elective surgeries resulted in a reduced number of surgeries being performed, which affected the market negatively. However, due to huge backlog and rise in efforts by the surgeons and healthcare facilities to generate higher revenue and fill in the demand & supply gap has helped the market to recover to great extent. Furthermore, the market represents lucrative opportunities with the world finally being able to combat and recover from the pandemic.
Hand-held Surgical Instruments Market Report Highlights:
- The forceps segment held the largest market share of 21.0% in 2024, owing to its increasing usage. Forceps are essential for grasping, holding, or manipulating tissues during surgeries, offering precision and control.
- The graspers segment is expected to experience maximum growth with a CAGR of 9.4% over the forecast period. Graspers are essential for holding, manipulating, or removing tissue during delicate procedures, offering enhanced precision and control.
- The orthopedic surgery segment held the largest market share of 20.9% in 2024 due to factors such as high incidence of Musculoskeletal (MSK) ailments and increasing developments in minimally invasive surgeries.
- The neurosurgery segment is expected to be the fastest-growing segment in the hand-held surgical instruments market, driven by the increasing prevalence of neurological disorders and advancements in surgical techniques.
- The hospitals segment held for the largest revenue share of 69.4% in 2024, owing large number of cases and preventive surgeries being performed in these settings.
- The clinics and ambulatory surgical centers segment is expected to experience rapid growth due to the increasing popularity of aesthetic and cosmetic surgeries in these centers.
- North American hand-held surgical instruments market held a dominant position, capturing 40.6% of the global revenue share in 2024.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Hand-held Surgical Instruments Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of chronic diseases
- 3.2.1.2. Increasing geriatric population
- 3.2.1.3. Rise in the number of road accidents
- 3.2.1.4. Rise in number of surgical procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Increase in the number of minimally invasive and non-invasive procedures
- 3.3. Hand-held Surgical Instruments Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Hand-held Surgical Instruments Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Hand-held Surgical Instruments Market: Product Movement Analysis
- 4.3. Hand-held Surgical Instruments Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Forceps
- 4.5.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Retractors
- 4.6.1. Retractors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Dilators
- 4.7.1. Dilators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Graspers
- 4.8.1. Graspers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9. Scalpels
- 4.9.1. Scalpels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.10. Cannulas
- 4.10.1. Cannulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.11. Dermatomes
- 4.11.1. Dermatomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.12. Trocars
- 4.12.1. Trocars Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.13. Others
- 4.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Hand-held Surgical Instruments Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Hand-held Surgical Instruments Market: Application Movement Analysis
- 5.3. Hand-held Surgical Instruments Market by Application Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Orthopedic Surgery
- 5.5.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Cardiology
- 5.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Ophthalmology
- 5.7.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Wound Care
- 5.8.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Audiology
- 5.9.1. Audiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10. Thoracic Surgery
- 5.10.1. Thoracic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.11. Urology and Gynecology Surgery
- 5.11.1. Urology and Gynecology Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.12. Plastic Surgery
- 5.12.1. Plastic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.13. Neurosurgery
- 5.13.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Hand-held Surgical Instruments Market: End-use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Hand-held Surgical Instruments Market: End-use Movement Analysis
- 6.3. Hand-held Surgical Instruments Market by End-use Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospitals
- 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Clinics
- 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Ambulatory Surgical Centers
- 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Others
- 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Hand-held Surgical Instruments Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Hand-held Surgical Instruments Market Movement Analysis
- 7.3. Hand-held Surgical Instruments Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North America Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1 Key Country Dynamics
- 7.5.2.2 Competitive Scenario
- 7.5.2.3 Regulatory Framework
- 7.5.2.4 Reimbursement scenario
- 7.5.2.5 U.S. Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1 Key Country Dynamics
- 7.5.3.2 Competitive Scenario
- 7.5.3.3 Regulatory Framework
- 7.5.3.4 Reimbursement scenario
- 7.5.3.5 Canada Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1 Key Country Dynamics
- 7.5.4.2 Competitive Scenario
- 7.5.4.3 Regulatory Framework
- 7.5.4.4 Reimbursement scenario
- 7.5.4.5 Mexico Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1 Key Country Dynamics
- 7.6.2.2 Competitive Scenario
- 7.6.2.3 Regulatory Framework
- 7.6.2.4 Reimbursement scenario
- 7.6.2.5 UK Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1 Key Country Dynamics
- 7.6.3.2 Competitive Scenario
- 7.6.3.3 Regulatory Framework
- 7.6.3.4 Reimbursement scenario
- 7.6.3.5 Germany Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1 Key Country Dynamics
- 7.6.4.2 Competitive Scenario
- 7.6.4.3 Regulatory Framework
- 7.6.4.4 Reimbursement scenario
- 7.6.4.5 France Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1 Key Country Dynamics
- 7.6.5.2 Competitive Scenario
- 7.6.5.3 Regulatory Framework
- 7.6.5.4 Reimbursement scenario
- 7.6.5.5 Italy Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1 Key Country Dynamics
- 7.6.6.2 Competitive Scenario
- 7.6.6.3 Regulatory Framework
- 7.6.6.4 Reimbursement scenario
- 7.6.6.5 Spain Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Denmark
- 7.6.7.1 Key Country Dynamics
- 7.6.7.2 Competitive Scenario
- 7.6.7.3 Regulatory Framework
- 7.6.7.4 Reimbursement scenario
- 7.6.7.5 Denmark Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1 Key Country Dynamics
- 7.6.8.2 Competitive Scenario
- 7.6.8.3 Regulatory Framework
- 7.6.8.4 Reimbursement scenario
- 7.6.8.5 Sweden Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.9. Norway
- 7.6.9.1 Key Country Dynamics
- 7.6.9.2 Competitive Scenario
- 7.6.9.3 Regulatory Framework
- 7.6.9.4 Reimbursement scenario
- 7.6.9.5 Norway Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Japan
- 7.7.2.1 Key Country Dynamics
- 7.7.2.2 Competitive Scenario
- 7.7.2.3 Regulatory Framework
- 7.7.2.4 Reimbursement scenario
- 7.7.2.5 Japan Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1 Key Country Dynamics
- 7.7.3.2 Competitive Scenario
- 7.7.3.3 Regulatory Framework
- 7.7.3.4 Reimbursement scenario
- 7.7.3.5 China Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1 Key Country Dynamics
- 7.7.4.2 Competitive Scenario
- 7.7.4.3 Regulatory Framework
- 7.7.4.4 Reimbursement scenario
- 7.7.4.5 India Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1 Key Country Dynamics
- 7.7.5.2 Competitive Scenario
- 7.7.5.3 Regulatory Framework
- 7.7.5.4 Reimbursement scenario
- 7.7.5.5 South Korea Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1 Key Country Dynamics
- 7.7.6.2 Competitive Scenario
- 7.7.6.3 Regulatory Framework
- 7.7.6.4 Reimbursement scenario
- 7.7.6.5 Australia Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1 Key Country Dynamics
- 7.7.7.2 Competitive Scenario
- 7.7.7.3 Regulatory Framework
- 7.7.7.4 Reimbursement scenario
- 7.7.7.5 Thailand Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1 Key Country Dynamics
- 7.8.2.2 Competitive Scenario
- 7.8.2.3 Regulatory Framework
- 7.8.2.4 Reimbursement scenario
- 7.8.2.5 Brazil Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1 Key Country Dynamics
- 7.8.3.2 Competitive Scenario
- 7.8.3.3 Regulatory Framework
- 7.8.3.4 Reimbursement scenario
- 7.8.3.5 Argentina Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9. Middle East & Africa
- 7.9.1. Middle East & Africa Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1 Key Country Dynamics
- 7.9.2.2 Competitive Scenario
- 7.9.2.3 Regulatory Framework
- 7.9.2.4 Reimbursement scenario
- 7.9.2.5 South Africa Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1 Key Country Dynamics
- 7.9.3.2 Competitive Scenario
- 7.9.3.3 Regulatory Framework
- 7.9.3.4 Reimbursement scenario
- 7.9.3.5 Saudi Arabia Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1 Key Country Dynamics
- 7.9.4.2 Competitive Scenario
- 7.9.4.3 Regulatory Framework
- 7.9.4.4 Reimbursement scenario
- 7.9.4.5 UAE Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1 Key Country Dynamics
- 7.9.5.2 Competitive Scenario
- 7.9.5.3 Regulatory Framework
- 7.9.5.4 Reimbursement scenario
- 7.9.5.5 Kuwait Hand-held Surgical Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Zimmer Biomet
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. B. Braun Melsungen AG
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Integra LifeSciences Corporation
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. . Medtronic, plc.
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Smith & Nephew
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Zimmer Biomet Holdings
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Johnson & Johnson Services, Inc.
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Becton, Dickinson and Company
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. CooperSurgical, Inc.
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Thompson Surgical Instruments Inc.
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. Aspen Surgical
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives